The ESMO 2019 Elections are around the corner. One member, one voice, one vote.
The most influential oncology meeting in Europe, in partnership with the EACR.
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Fabrice André, Editor-in-chief of Annals of Oncology, explains what are the new directions the journal will take: focus on innovation and access to innovation, as well as more commentaries and debate around scientific questions.
22 May 2019
Automated prediction of malignancy risk of pulmonary nodules in chest CT scan
21 May 2019
Abstracts submission is now open
21 May 2019
Results of the TONIC trial
20 May 2019
Approval is based on results from the CLL14 study
17 May 2019
Approval is based on results from the JAVELIN Renal 101 study
16 May 2019
Acceleration of cancer research by use of model cancer cell lines
Kazan, Russian Federation
10 Jun
- 11 Jun
2019
Barcelona, Spain
14 Jun
- 15 Jun
2019
Zeist, Netherlands
15 Jun
- 21 Jun
2019
Barcelona, Spain
03 Jul
- 06 Jul
2019
Zurich, Switzerland
03 Jul
- 04 Jul
2019
Valencia, Spain
18 Jul
- 23 Jul
2019
